D. E. Shaw & Co., Inc. Elanco Animal Health Inc Transaction History
D. E. Shaw & Co., Inc.
- $122 Billion
- Q4 2024
A detailed history of D. E. Shaw & Co., Inc. transactions in Elanco Animal Health Inc stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 660,639 shares of ELAN stock, worth $7.38 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
660,639
Previous 1,028,624
35.77%
Holding current value
$7.38 Million
Previous $15.1 Million
47.02%
% of portfolio
0.01%
Previous 0.01%
Shares
26 transactions
Others Institutions Holding ELAN
# of Institutions
439Shares Held
448MCall Options Held
1.16MPut Options Held
1.12M-
Dodge & Cox San Francisco, CA83.2MShares$929 Million0.63% of portfolio
-
Primecap Management CO Pasadena, CA51.2MShares$572 Million0.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA48.8MShares$545 Million0.01% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$260 Million0.01% of portfolio
-
Black Creek Investment Management Inc. Toronto, A620.4MShares$228 Million11.79% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $5.3B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...